[A case of complete response (CR) persisting for 2 years from S-1 administered five days a week in a patient with gastric cancer].
We attempted S-1 administered five days a week from March, 2004 for an 84-year-old female harboring Borrmann type 1 gastric cancer because her family did not agree to her gastrectomy. After treatment for 1 month the lesion changed into a shallow ulcer. The lesion was clinically diagnosed with CR about 3 months later. As of October, 2006, 2 years after inducing CR, we have been administering S-1 to the patient, with no regrowth of the tumor.
Tsuchiya
Kuniyuki
K
Dept. of Surgery, Omihachiman Community Medical Center.
Miyagi
Hisayuki
H
Okugawa
Kaori
K
Nakamura
Kenji
K
Nakano
Katsunori
K
Osaka
Yoshio
Y
Takahashi
Shigeru
S
Sako
Hirotaka
H
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D006801:Humans; D010094:Oxonic Acid / Q000627:therapeutic use*; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005641:Tegafur / Q000627:therapeutic use*
D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid